Floatz logo

Arestin

Back Pain Lower Back Chronic

Marco LoggiaPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Back Pain Lower Back Chronic cohort.

Asset / SponsorPhaseRating
Buprenorphine
Carolinas Pain Institute
Phase 4BB
Duloxetine
Eli Lilly and Company
Phase 3BB
Etoricoxib
Muhammad Ilyas
Phase 4BB
Activematrix
Baylor College of Medicine
Phase 4BB
OXYCODONE HYDROCHLORIDE, HYDROCODONE-
Zogenix, Inc.
Phase 3BB

View all 10 →

Same molecule, other indications

Arestin is also rated in:

mood disorderDormant
BBB
Indicative ·
73 / 100
View asset →
bipolar depressionDormant
BB
Indicative ·
70 / 100
View asset →
ischemic strokeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →